About PTEN
No gene-level summary was recorded for this case.
No variant summary was recorded for this case.
Five-step scale from benign to pathogenic. This variant is uncertain. Select a step to read what it means.
Uncertain.The recorded classification is uncertain significance.
Gene-level background from the recorded interpretation.
Words with a dotted underline have a short definition. Hover or tap them.No gene-level summary was recorded for this case.
The recorded framework is ClinGen PTEN VCEP v3.2.0. The criteria and strengths shown below come from the saved assessment; this page does not recalculate the classification.
The applied criteria and their strengths are shown as assessed under the stated framework.
No pathogenic criterion marked as applied in the recorded assessment.
The gnomAD v4.1 filtering allele frequency is 6.24e-06, which falls within the PTEN BS1_Supporting range of 0.0000043 to 0.000043 and below the BS1 strong range of 0.000043 to 0.00056; therefore BS1 is met at supporting strength.
Richards et.al., 2015 - Combining rules v3.2.0 criteria-combination framework was evaluated deterministically with applied criteria: BS1 supporting; no rule matched the adjudicated criteria.
Evidence summaries and captured source records, where available. Missing entries should not be interpreted as negative findings.
gnomAD v4.1: 6 / 492,096 alleles. Recorded AF 1.21927e-05. Recorded homozygote count 0.
Absent from gnomAD v2.1.
Recorded SpliceAI maximum delta score: 0.000. Refer to the recorded PP3/BP4 rationale for interpretation.
A ClinVar laboratory submission summary was not recorded.
No standalone functional evidence summary is recorded in evidence_summary.functional.
This variant has not previously been reported in somatic cancers (COSMIC).
ACMG/AMP criteria under ClinGen PTEN VCEP v3.2.0, with the data and sources behind each one.
28 criteria with recorded statuses: 1 met · 4 not met · 12 not assessed · 11 not applicable. Open any row for the full reasoning, the rule and the evidence behind it.
The PTEN NM_000314.8:c.-361C>T (NP_000305.3:p.?) variant has not been reported in ClinVar.
This variant is absent from gnomAD v2.1 but present in gnomAD v4.1 at 6/492096 alleles, with filtering allele frequency 6.24e-06; this is above the PTEN PM2 cutoff and within the PTEN BS1_supporting frequency range.
No criteria match.
BS1_Supporting
PTEN VCEP PVS1 decision tree
Every interpreted variant in PTEN, mapped onto the exon structure of NM_000314.8. Select a row to find it on the plot.
| Protein | Location | Classification | Link |
|---|
| Remaining individuals1 / 22,456 | 4.5e-05 |
| European (non-Finnish)5 / 279,178 | 1.8e-05 |
This variant is present in gnomAD v4.1 (AF= 1.21927e-05; MAF= 0.00122%, 6/492096 alleles, homozygotes = 0) and has highest observed frequency in the Remaining individuals population (AF= 4.45315e-05; MAF= 0.00445%, 1/22456 alleles, homozygotes = 0); grpmax FAF= 6.24e-06.
Absent from gnomAD v2.1.
SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00).
0 paper records listed. No publication is explicitly linked to an applied criterion in the recorded metadata.
Screenshots represent source records captured during evidence collection. Select one to view the recorded source content.
The evidence statements recorded by the interpretation pipeline. They have not been reinterpreted by the page.
This variant is present in gnomAD v4.1 (AF= 1.21927e-05; MAF= 0.00122%, 6/492096 alleles, homozygotes = 0) and has highest observed frequency in the Remaining individuals population (AF= 4.45315e-05; MAF= 0.00445%, 1/22456 alleles, homozygotes = 0); grpmax FAF= 6.24e-06.
Absent from gnomAD v2.1.
This variant is absent from ClinVar.
SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00).
This variant has not previously been reported in somatic cancers (COSMIC).